Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14
[1] It is important to note that the FDA has not yet approved GLP-1 agonists for treating type 1 diabetes, but some healthcare providers may prescribe them off-label
Ambrosino P, Bachetti T, DAnna SE, Galloway B, Bianco A, DAgnano V, et al
Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A
1-4 Minimizing use of these agents when possible can also help reduce the risk of false-positive results
Some providers extend individual steps to 6 or 8 weeks if patients experience significant side effects at a new dose level
When medically appropriate, we prescribe GLP-1s for conditions like cardiac and vascular disease, sleep apnea, kidney disease, type 2 diabetes and stroke risk
US$ 23.64
US$ 21.24
US$ 29.83
US$ 20.81
US$ 28.95
US$ 21.49
US$ 29.28
